Last €88.30 EUR
Change Today +0.69 / 0.78%
Volume 7.0K
AMG On Other Exchanges
Symbol
Exchange
Hong Kong
Mexico
NASDAQ GS
Sao Paulo
Frankfurt
As of 8:44 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Anthony C. Hooper

Executive Vice President of Global Commercial Operations, Amgen Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

59$6,179,503
As of Fiscal Year 2013

Background*

Mr. Anthony C. Hooper, also known as Tony, has been an Executive Vice President of Global Commercial Operations at Amgen Inc., since October 2011. Mr. Hooper is responsible for Amgen's Global Commercial Operations. He served as President of US, Japan and Intercontinental and Senior Vice President of Commercial Operations at Bristol-Myers Squibb Company until October 2011. Mr. Hooper served as the President of Americas of Bristol-Myers Squibb Company since March 3, 2009. ...

Read Full Background

Corporate Headquarters*

One Amgen Center Drive
Thousand Oaks, California 91320

United States

Phone: 805-447-1000
Fax: 805-447-1010

Board Members Memberships*

2010-N/A
Former Director

Education*

LLB
University of South Africa
MBA
University of South Africa

Other Affiliations*

Annual Compensation*

Salary$1,001,858
Total Annual Compensation$1,001,858

Stock Options*

Restricted Stock Awards$3,199,895
All Other Compensation$300,750

Total Compensation*

Total Annual Cash Compensation$2,979,608
Total Short Term Compensation$1,001,858
Other Long Term Compensation$3,500,645
Total Calculated Compensation$6,179,503
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMG:GR €88.30 EUR +0.69

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.